Cancer

Title
A Registry to Collect Information on Participants who have Metastatic Renal Cell Cancer or Metastatic Melanoma and are Currently Prescribed the Study Medication Interleukin-2
Trial Number
203928101311
Number of Participants
1,500
Principal Investigator

Joseph Clark

M.D.
Hematology/Oncology
Professor
Eligibility

Entry Criteria for Retrospective Cohort:
-18 years of age or older
-Received HD IL-2 at the site prior to site initiation
-Have conformed to site-specific guidelines permitting research on medical records without personal identification

Purpose

The main reason why this registry is being set up is to collect information on participants who are receiving treatment with Interleukin-2 in an organized way to learn more about patient care during and after treatment.

Enrollment

708-327-3221

MORE CLINICAL TRIALS

Clinical Trials

For more information call (888) LUHS-888.